HealthShares Dermatology and Wound Care ETF [ HRW ]

HealthShares™ Dermatology and Wound Care ETF (HRW) is one in a series of HealthShares™ ETFs that are organized Vertically by therapeutic categories in pharmaceuticals, healthcare services, life sciences and biotechnology. HRW seeks investment results that correspond to the performance, before the Fund’s fees and expenses, of HealthShares™ Dermatology and Wound Care Index, an equity index of publicly traded common stocks and ADRs. The Dermatology and Wound Care Index invests in healthcare, life sciences and/or biotechnology companies that have been identified as dermatology and wound care companies. Companies included in the Dermatology and Wound Care Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of skin disorders by topical or systemic means. Targeted diseases include, but are not limited to, acne, rosacea, psoriasis, genital warts and atopic dermatitis. The companies in this universe are selected using a proprietary methodology developed by XShares Group LLC designed to identify companies in a specific healthcare vertical or sub-sector.

HRW employs a low-cost passive management investment approach designed to track the performance of the HealthShares™ Dermatology and Wound Care Index. Normal brokerage fees apply. HRW will generally invest at least 90% of its assets in common stocks of companies in the underlying Index.

HRW intends to pay out any dividends from its net investment income annually, and plans to distribute any net capital gains annually.

XShares Advisors LLC is the investment advisor for HRW. Bank of New York acts as custodian and administrator.

* Last Sale.

** Indicative Optimized Portfolio Value.

*** Bid/Ask Midpoint versus NAV.